Approaches to hepatitis C treatment and cure using NS5A inhibitors | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, et al. Approaches to hepatitis C treatment and cure using NS5A inhibitors. Infect Drug Resist. 2014;7:41-56.

Publication Type:

Journal Article

Authors:

Kohler, J.J.; Nettles, J.H.; Amblard, F.; Hurwitz, S.J.; Bassit, L.; Stanton, R.A.; Ehteshami, M.; Schinazi, R.F.

Source:

Infect Drug Resist, Volume 7, p.41-56 (2014)

Keywords:

AIDS, Antiviral Agents, Biology, CLASS, clinical trial, Clinical Trials, Drug Resistance, HCV, hepatitis, Hepatitis C, hepatitis C virus, In Vitro, Medicine, Mutation, NS5A inhibitor, Pediatrics, protease inhibitor, Protease Inhibitors, Proteins, PROVIDE, Research, resistance, treatment, Universities, Veterans, Viral Proteins, Viruses

Notes:

PMC3949698

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24623983

Export Citation:

RIS Format

Top